Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 95 | BSPED2023 | Next issue

50th Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Manchester, UK
08 Nov 2023 - 10 Nov 2023

Card image cap
The 50th Annual BSPED Meeting will take place at the Midland Hotel, Manchester from 8-10 November 2023.

Poster Presentations

Gonadal, DSD and Reproduction 2

ea0095p120 | Gonadal, DSD and Reproduction 2 | BSPED2023

Multidisciplinary team management in an andrology service for Klinefelter Syndrome: A review of current practice

Alexopoulou Vasiliki , Bambang Katerina , Senniappan Senthil

Background: Klinefelter Syndrome (KS) affects approximately 1 in 500 males and presents with different phenotypes. KS affects spermatogenesis and causes infertility but can also impact neurocognitive and psychological development or affect other systems like cardiovascular, dental, skeletal. European Academy of Andrology has published recommendations regarding holistic KS management, including the fertility aspects, from childhood until adulthood.<p class=...

ea0095p121 | Gonadal, DSD and Reproduction 2 | BSPED2023

Characterising puberty in children and young people with Alstrom Syndrome

Anwunah Ijeoma , Barrett Tim , Kershaw Melanie

Background: Alstrom syndrome (AS) is a very rare multisystem disorder secondary to mutations in the ALMS1 gene, associated with infantile cardiomyopathy, retinal dystrophy, early onset obesity, and diabetes. Whilst a previous international review, including 35 males, cited pubertal delay and hypogonadism to be common, no detailed characterisation of puberty exists. This retrospective longitudinal analysis aims to describe puberty in boys with AS.<p class="...

ea0095p122 | Gonadal, DSD and Reproduction 2 | BSPED2023

Characterisation of children and young people (CYP) presenting with differences in sex development (DSD) beyond the neonatal period: A single centre retrospective observational study

Shirodkar Diksha , Baioumi Alaa , Giri Dinesh , Candler Toby , Burren Christine , Hamblin Rachel , Alderson Julie , Crowne Elizabeth

Introduction: DSD includes variations in the development of chromosomal, gonadal, or anatomical sex and can be subdivided into (XY DSD, XX DSD, and sex chromosomal DSD). Most presentations occur in the neonatal period with atypical genitalia or discordant phenotype and antenatal genotype, but later presentations occur raising complex diagnostic and clinical management issues.Objective: To characterise the etiological, cl...

ea0095p123 | Gonadal, DSD and Reproduction 2 | BSPED2023

Testosterone therapy in Duchenne muscular dystrophy and longitudinal bone growth with metacarpophalangeal length measurement

McCauley Cara , Dunne Jennifer , Horrocks Iain , Joseph Shuko , Wong Sze Choong

Background: Testosterone therapy is recommended for the management of puberty in Duchenne muscular dystrophy (DMD) from 12 years, according to the 2018 international standards of care with studies demonstrating improvement in linear growth. The majority become non-ambulant during mid-to-late adolescence. Accurately measuring height in non-ambulant adolescent boys can be challenging compounded by lower limb contractures. Estimated height from segmental body par...

ea0095p124 | Gonadal, DSD and Reproduction 2 | BSPED2023

The value of the stimulated testosterone: dihydrotestosterone ratio in 46, XY DSD due to 5alpha-reductase type 2 deficiency

Balagamage Chamila , Igbokwe Rebecca , Idkowiak Jan , Mohamed Zainaba

Introduction: Testosterone(T) is converted to dihydrotestosterone(DHT), the most potent androgen, by the enzyme 5alpha-reductase type 2(SRD5A2). During foetal development, the masculinisation of male external genitalia crucially depends on DHT. Pathogenic variants in SRD5A2 cause 46,XY differences in sex differentiation(DSD). Early and accurate diagnosis is paramount to facilitate gender assignment since most reared as females may profoundly virilize at pubert...

ea0095p125 | Gonadal, DSD and Reproduction 2 | BSPED2023

Audit of the investigations and treatment for adolescents with irregular menstruation/suspected Polycystic Ovarian Syndrome at The Noah’s Ark Children’s Hospital for Wales

Aneva Katrin , Rees Professor Aled , Williams Dr Georgina

Objective: Diagnostic uncertainty arises for paediatric patients when establishing a diagnosis of polycystic ovarian syndrome (PCOS) due to concurrent pubertal changes. Management decisions can also therefore be challenging. The investigations and management of patients referred to the Paediatric Endocrinology Service was audited against international guidelines.Methods: Retrospective audit of patients referred with susp...

ea0095p126 | Gonadal, DSD and Reproduction 2 | BSPED2023

A case of 46, XY differences of sex development (DSD) due to FKBP4 deficiency: A novel candidate of androgen insensitivity syndrome?

Balagamage Chamila , Igbokwe Rebecca , Robinson Hannah , McCarthy Liam , Chandran Harish , Godber Caroline , Mohamed Zainaba , Idkowiak Jan

Introduction: FKBP prolyl isomerase 4, encoded by the gene FKBP4, is a member of the FK506-binding protein family and is presumed to be a regulator of the androgen receptor (AR) pathway. Mutations in FKBP4 have been proposed to cause Androgen Insensitivity Syndrome (AIS), with only one case reported in the literature so far.Aim: To report the clinical, biochemical and genetic findings in an infant with 46, XY DSD a homoz...

ea0095p127 | Gonadal, DSD and Reproduction 2 | BSPED2023

Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency

Riaz Maira , Yasir Mehrunnisa , Rathor Heeranand , Ibrahim Mohsina

17-beta hydroxysteroid dehydrogenase 3 deficiency is a condition that affects male sexual development. People with this condition are genetically male, with gonads (testes) intact. Their bodies, however, do not produce enough testosterone. Testosterone has a critical role in male sexual development, and a shortage of this hormone disrupts the formation of the male phenotype of external genitalia before birth.Case report: 12 years old, re...

ea0095p128 | Gonadal, DSD and Reproduction 2 | BSPED2023

Challenging clinical scenario: Germ cell tumor masquerading as peripheral precocious puberty in a one-year-old boy from Pakistan

Versha Rani Rai , Mohsina Noor Ibrahim , Sanagar Ali , Maira Riaz , Roshia Parveen , Mehrunnisa Yasir

Peripheral precocious puberty (PPP) in males is a rare condition characterized by the premature activation of the hypothalamic–pituitary–gonadal axis, resulting in the early onset of secondary sexual characteristics. We present the case of a one-year-old boy from Pakistan who exhibited PPP along with a left hip region mass.The patient’s initial workup revealed remarkably elevated levels of beta-human chorionic gonadotropin (Bhcg) and serum alphafetoprotein (AFP), indicating po...

ea0095p129 | Gonadal, DSD and Reproduction 2 | BSPED2023

Kallmann syndrome: A FGFR1 mutation

Clemente Marisa , Naghmuish Eiman , Weerasinghe Kamal

Introduction: Kallmann syndrome (KS) is a developmental disorder characterised by hypogonadotropic hypogonadism and anosmia. 30% of cases are related with genetic causes, with FGFR1 mutations being identified in 10%. There are more than 140 FGFR1 gene mutations identified. We present a female patient with KS due to a FGFR1 mutation, where the presenting features included primary amenorrhoea and anosmia.Case description: ...